Tranche Update on InBody Co., Ltd.'s Equity Buyback Plan announced on March 13, 2020.
September 17, 2020 at 12:26 am EDT
Share
From April 1, 2020 to June 30, 2020, the company has repurchased 220,988 shares, representing 1.67% for KRW 4,205.43 million. With this, the company has completed the repurchase of 274,995 shares, representing 2.07% for KRW 4,986.97 million under the buyback announced on March 13, 2020.
InBody Co., Ltd., formerly Biospace Co., Ltd., is a Korea-based company engaged in the manufacture of electronic medical devices. The Company mainly produces body composition analyzers under the brand names of InBody and LookinâBody. The Company mainly produces body composition analyzers under the brand name InBody and LookinâBody. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include LookinâBody3.0 and LookinâBody Basic, which are used for measuring proteins, minerals, fats, moistures and others. It also provides body mass index (BMI) measuring devices under the brand name of BSM. The Company distributes its products within domestic market and to overseas markets.
INBODY CO.,LTD 
